NEWS & EVENTS

Alcami Presenting Environmental Monitoring Webinar on November 18

Alcami Attending CPhI Festival of Pharma

Alcami Continues to Execute Strategic Plan to Focus Its Platform with Sterling Pharma Solutions’ Acquisition of API Facility in US

Alcami Hosting Virtual Open House of New Sterile Fill-Finish Development & Manufacturing Facility

Food Studies 101

Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK

Alcami RTP Expansion Nears Completion

505(b)(2): What You Need to Know

Roundtable Discussion with Pharma's Almanac: Greatest Drug Molecules to Impact Society & the Pharmaceutical Industry

Reducing Risk with Abuse‑Deterrent Formulations

Alcami Appoints Walter J. Kaczmarek III as Chief Executive Officer

Alcami Continues to Strengthen Senior Leadership Team with Appointment of Quality and Regulatory Leaders

Alcami Appoints EVP of Drug Product Operations and VP of Laboratory Operations

Component Selection Equates to Successful Sterile Fill-Finish Manufacturing

Alcami Announces Senior Leadership Appointments

Successful Methods for Obtaining Orphan Drug Approval

Alcami Supporting Potential COVID-19 Treatment

Editorial: Challenge Accepted! Problem-Solving Examples for Packaging Dilemmas

The Benefits of Establishing a Full-Time Equivalent (FTE) Program with Your Contract Service Provider

Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

SCIENTIST SPOTLIGHT: Katie Shupe

Alcami Corporation Expanding Operations in Charleston County

SCIENTIST SPOTLIGHT: Norman Chieng

The Importance of Secondary Packaging

SCIENTIST SPOTLIGHT: Scott Reed

Alcami Launches New Rapid Sterility Testing Services

ON-DEMAND WEBINAR: Rapid Sterility Capabilities and Benefits

The Changing R&D Landscape: Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)

Editorial: Considerations for Approval of Biosimilars

eBook: Analytical Testing in Drug Development

A 3-Minute Introduction To Rapid Sterility Testing

SCIENTIST SPOTLIGHT: Shakia Carlos-Barr

Introduction to Quality by Design

Case Study: Abeona Therapeutics

SCIENTIST SPOTLIGHT: Devon Dodd

Regulatory Requirements for Early Phase Drug Product Development

Editorial: Designing a CMC Strategy for Accelerated Development of Biotherapeutics

Editorial: Novel Therapies Roundtable Discussion

Stability: Top Testing Factors You Should Consider

Alcami St. Louis Facility Issued European Medicines Agency Certification

Editorial: Overcoming the Opioid Overdose Crisis

White Paper: Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

Understanding Biologics: Your Top 7 Questions Answered

Video: Extractables and Leachables

SCIENTIST SPOTLIGHT: Czarina Carino

eBook: Elemental Impurities

ON-DEMAND WEBINAR: The Importance of Microbial In-Use Studies

Editorial: An Interview with Alcami Parenteral Experts

ON-DEMAND WEBINAR: Early Phase Development of Biologics

Editorial: Oral Solids Endure & Evolve

Beyond the Bench: UNC Wilmington Classroom to cGMP Laboratories

Staying Ahead of OSD Challenges

SCIENTIST SPOTLIGHT: Marilyn Heidbrink

Editorial: Outsourcing Analytical Testing - The Gateway to Drug Manufacturing

Editorial: A Practical Approach to Extractables & Leachables

The Top 5 Most Asked Extractables & Leachables Questions Answered

SCIENTIST SPOTLIGHT: Matthew Collmeyer

Video: Alcami's Oral Solid Dose Manufacturing

Agency-Accepted Testing and Filing Strategy for Elemental Impurities

Case Study: Medicines Development for Global Health

The Top 8 Most Asked Questions about Microbial In-Use Studies

White Paper: Insight into Orphan Drug Formulations and Regulations

Beyond the Label: Four Challenges to Serialization

Important Steps for Quota, Import, and Export Processes for DEA Controlled Substances

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

SCIENTIST SPOTLIGHT: Steven Froelich

ON-DEMAND WEBINAR: Extractables & Leachables

Alcami and UNCW Awarded Biomanufacturing Workforce Development Grant

SCIENTIST SPOTLIGHT: Kourtney Bergeron

Formulating for Orphan Indication Drug Products

Considerations for Abuse-Deterrent Category One Syringeability Studies

The Role of Full Time Equivalent (FTE) Programs

ON-DEMAND WEBINAR: Elemental Impurities

Alcami Announces Donation to Wilmington, North Carolina Fire Department

Alcami’s Extended Workbench Supports Commercial Supply of Flexion Therapeutics’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Case Study: Implementing Serialization

Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners

SCIENTIST SPOTLIGHT: Jack James

Beyond the Bench: A Century of Experience

Elevate Product Stewardship and Exceed Your Sustainability Goals

Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

Case Study: Challenges and Solutions to Formulating an Orphan Drug

SCIENTIST SPOTLIGHT: Michelle Shelton

Understanding Pharmaceutical Packaging

Panel Discussion: Oral Solid Dosage Manufacturing Process 

Editorial: Is Industry Ready for the Serialisation Shake-Up?

Alcami Donation to Outfit TROSA Medical Department

Editorial: Transparent and Timely Testing

Serialization CDMO Checklist

Editorial: Stability Testing Ensures Proper Packaging for Drug Storage

Editorial: Tackling the Opioid Crisis with Abuse-Deterrent Formulations

Stability: Back to the Basics - Part V

SCIENTIST SPOTLIGHT: Angela Moore

Beyond the Bench: Analytical Development and Professional Growth

Editorial: Analytical Testing - Contractors Take on the Challenge of Complex Molecules

SCIENTIST SPOTLIGHT: Elizabeth Oxendine

Stability: Back to the Basics - Part IV

SCIENTIST SPOTLIGHT: Colleen Guthrie

ON-DEMAND WEBINAR: Abuse-Deterrent Category One Testing: Syringeability Studies

Stability: Back to the Basics - Part III

Abuse-Deterrent Studies – An Interview with Angela Moore

Q&A on Filter Validation

Alcami Wins Prestigious Business of the Year Award from St. Louis Mayor

SCIENTIST SPOTLIGHT: Stephanie Jarman

Stability: Back to the Basics - Part II

Editorial: Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

Stability: Back to the Basics - Part I

St. Louis, Missouri Laboratory in Cortex Innovation Community

Framework to Biologics – Part Three

Framework to Biologics – Part Two

Framework to Biologics – A Three Part Series

Alcami Corporation and the University of North Carolina Wilmington Announce Academic Partnership

Video: Charleston Regional Development Alliance Features Alcami

Editorial: Oral Solid Dosage Manufacturing Roundtable

Editorial: Implications of Serialization for the U.S. Pharma Industry

Alcami Awarded for 2016 Manufacturing and Laboratories Operations Performance

In-Use Stability Testing: Providing the Right Instructions

Serialization - Data Management Challenges

Limited Lab Capacity? An Extended Workbench Program can help

Extractables and Leachables – Why?

Serialization Overview: What’s Required for November 27, 2017 Deadline

Bringing the Light to Photostability in Three Parts - Part Three

Bringing the Light to Photostability in Three Parts - Part Two

Alcami Announces Extended Workbench Offering for Analytical Services

Bringing the Light to Photostability in Three Parts

SCIENTIST SPOTLIGHT: Elsie Melsopp

Antibiotic Potency Testing: The Methods - Part 2

Antibiotic Potency Testing: The Methods – Part 1

SCIENTIST SPOTLIGHT: Christopher Williams

Elemental Impurities: The Risk-Based Approach

Overview and Performance of the Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics

The Effect of Abuse-Deterrent Formulations on Opioid Abuse

Elemental Impurities: Updated Regulatory Requirements

Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities

St. Louis Relocation Regulatory Change Notification

Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters

Alcami Invests in MicroSEQ® Rapid Microbial Identification System to Expand its Service Capabilities at Four U.S. Sites

Investment of $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO

Expanding Capabilities and Capacity for Sterile Drug Product Manufacturing in Charleston, SC

Additional Equipment and Capacity for Drug Product Manufacturing in Wilmington, NC

Bolstering Capabilities For Parenteral Drug Development and Manufacturing